BIOMAT Database Logo BIOMAT Database Logo

Progressive multifocal leukoencephalopathy (PML) after transplantation. 2011

Christina Nguyen, and Ron Shapiro

UI MeSH Term Description Entries
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016377 Organ Transplantation Transference of an organ between individuals of the same species or between individuals of different species. Grafting, Organ,Transplantation, Organ,Graftings, Organ,Organ Grafting,Organ Graftings,Organ Transplantations,Transplantations, Organ
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised

Related Publications

Christina Nguyen, and Ron Shapiro
[Progressive multifocal leukoencephalopathy (PML)].
November 2011, Rinsho shinkeigaku = Clinical neurology,
Christina Nguyen, and Ron Shapiro
[Progressive multifocal leukoencephalopathy (PML)].
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
Christina Nguyen, and Ron Shapiro
Progressive multifocal leukoencephalopathy (PML).
April 1998, Project Inform perspective,
Christina Nguyen, and Ron Shapiro
[PML: progressive multifocal leukoencephalopathy].
April 1997, Rontgenpraxis; Zeitschrift fur radiologische Technik,
Christina Nguyen, and Ron Shapiro
Progressive multifocal leukoencephalopathy (PML) in AIDS.
December 1988, Neurology,
Christina Nguyen, and Ron Shapiro
[Progressive multifocal leukoencephalopathy after kidney transplantation].
January 1974, Revue neurologique,
Christina Nguyen, and Ron Shapiro
Progressive multifocal leukoencephalopathy after cardiac transplantation.
June 1988, Neurology,
Christina Nguyen, and Ron Shapiro
Spontaneous progressive multifocal leukoencephalopathy (PML) in macaques.
April 1975, Nature,
Christina Nguyen, and Ron Shapiro
Cerebellar form of progressive multifocal leukoencephalopathy (PML).
May 1979, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
Christina Nguyen, and Ron Shapiro
Progressive multifocal leukoencephalopathy after orthotopic liver transplantation.
November 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Copied contents to your clipboard!